Back to MW MARSHALL WACE, LLP

EGRXEGRX
15 quarters

Position history for MWMARSHALL WACE, LLP's holdings in EAGLE PHARMACEUTICALS INC

MARSHALL WACE, LLP previously held 0 shares of EGRX (EAGLE PHARMACEUTICALS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$4.5M

Total Shares Change

-111,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Increased
223,353
+14.3%
$833,1070.0%$3.95
28
2024-Q2
Decreased
195,475
-24.1%
$1.1M0.0%$5.60
0
2024-Q1
Increased
257,469
+79.0%
$1.3M0.0%$5.24
39
2023-Q4
New
143,826
-
$752,2100.0%$5.23
34
2023-Q2
Exited
0
-100.0%
$00.0%$19.47
0
2023-Q1
Increased
65,967
+331.8%
$1.9M0.0%$27.88
42
2022-Q4
New
15,276
-
$446,5170.0%$29.23
33
2021-Q2
Exited
0
-100.0%
$00.0%$42.14
0
2021-Q1
New
23,449
-
$979,0000.0%$41.06
35
2019-Q4
Exited
0
-100.0%
$00.0%$59.89
0
2019-Q3
Increased
51,590
+45.1%
$2.9M0.0%$56.43
36
2019-Q2
Decreased
35,550
-64.6%
$2M0.0%$55.68
0
2019-Q1
Decreased
100,376
-9.9%
$5.1M0.0%$50.49
0
2018-Q4
New
111,464
-
$4.5M0.0%$39.23
37

Other major holders of EGRX: BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used